InsiderTrades

Form 4 for BCDA BioCardia, Inc.

Accepted 2026-07-07 22:02:00 ET · period of report 2026-07-02 · accession 0001437749-26-022967 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-07-07 22:02 2026-07-02 BCDA GILLIS EDWARD M SVP, Devices F - Tax $1.24 -17.3K 54.1K -24% -$21.4K
D 2026-07-07 22:02 2026-07-06 BCDA GILLIS EDWARD M SVP, Devices A - Grant $0.00 +29.4K 61.1K +93% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-02 F D 17,269 $1.24 54,126 D — — (F1) The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. (F1) The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person.
2 Derivative Stock Option (right to buy) 2026-07-06 A A 29,442 $0.00 61,139 D $1.20 · — to 2036-07-06 29,442 Common stock (F2) The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.